| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |